The objective of this study was to determine the mechanism and effect of
hematoporphyrin monomethyl ether mediated
photodynamic therapy (HMME-
PDT) on
oral squamous cell carcinoma (OSCC). Human OSCC CAL-27 cells were randomly divided into four groups: control group, HMME group,
laser group, and HMME-
PDT group. Cell viability was detected by the
CCK-8 method. Cell cycle distribution was evaluated by flow cytometry. GEO database was used to screen differentially expressed
microRNAs (DEMs), and TCGA database was performed to verify DEM expression in OSCC and normal tissues. The effects of HMME-
PDT on DEM expression were assayed by real-time PCR, and the expressions of
miRNAs target genes were measured by western blot. Fluorescence probes were used to determine the production of
singlet oxygen (1O2). Compared with the other three groups, HMME-
PDT dramatically inhibited CAL-27 cell proliferation and induced G0/G1 cycle arrest. The expressions of miR-21 and miR-155 were significantly upregulated in OSCC. HMME-
PDT downregulated the expression of miR-21 but had no obvious effect on miR-155. HMME-
PDT remarkably upregulated the levels of P53 and miR-21 target
proteins, such as PDCD4, RECK, and SPRY2. 1O2 was generated during HMME-
PDT, and inhibition of 1O2 production could reverse the regulation of HMME-
PDT on P53, miR-21, and its target
proteins, thus restoring cell viability. HMME-
PDT can significantly inhibit the growth of OSCC cells, and the mechanism of this effect is related to the regulation of the P53-miR-21-PDCD4 axis via 1O2 induced by HMME-
PDT.